![Cheri Walker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cheri Walker
Präsident bei Firefly BioWorks, Inc.
Aktive Positionen von Cheri Walker
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Brickbio, Inc.
![]() Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Direktor/Vorstandsmitglied | - | - |
Firefly BioWorks, Inc.
![]() Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Präsident | - | - |
Karriereverlauf von Cheri Walker
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 2 |
President | 1 |
Sektoral
Technology Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Brickbio, Inc.
![]() Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Technology Services |
Firefly BioWorks, Inc.
![]() Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Cheri Walker
- Erfahrung